Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation

BACKGROUND: Prevention of thromboembolism by novel oral anticoagulants is increasing, whilst use of vitamin K antagonists is on the decline. We assessed changes in the use of these anticoagulants in treating non-valvular atrial fibrillation between 2014 and 2018. METHODS: One-hundred and sixty-two c...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkinshaw, Alexander, Fry, Christopher H, Fluck, David, Sharma, Pankaj, Han, Thang S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119231/
https://www.ncbi.nlm.nih.gov/pubmed/32284860
http://dx.doi.org/10.1177/2048004020915406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119231/
https://www.ncbi.nlm.nih.gov/pubmed/32284860
http://dx.doi.org/10.1177/2048004020915406

Ejemplares similares